Pentavere is a Patient Identification Company that has built a best in class AI engine to identify patients that are eligible for approved medications or interventions, to improve outcomes for patients and help drive therapy growth and penetration.
Pentavere and DARWEN™ AI have received significant acclaim from
major global pharmaceutical companies and healthcare leaders:
"Pentavere allows us to query our lung cancer data to give us an accurate snapshot of current clinical practice for advanced lung cancer patients."
"We are thrilled to have the opportunity to collaborate with Pentavere to leverage their AI technology within the field of rare diseases."
“Darwen enables the automation of data abstraction from unstructured hospital electronic medical records and may eliminate the need for manual chart review.”
“Thanks to Pentavere's innovative AI technology, the dismal scenario for rare disease patients could soon change. We are so proud and excited to have the opportunity to work with Pentavere’s AI and apply it to help rare diseases in Canada.”
“In a world drowning in data but thirsting for knowledge, Pentavere has cast a light on ways to alleviate this challenge. Companies like Pentavere will bring healthcare into the 21st century.”
Previous
Next
Publications & Validation
Press
Pentavere has been nominated for the coveted 2022 Prix Galien USA Award for best Digital Startup in the industry
- Newswire
“We are thrilled to have the opportunity to collaborate with Pentavere to leverage their AI technology within the field of rare diseases”
- Newswire
The initiative is relying on Pentavere’s proprietary natural language processing (NLP) engine called DARWEN to extract real world patient evidence and insights
- Canadian Healthcare Technology Magazine
